New York, NY -- (SBWIRE) -- 01/03/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Mitsubishi UFJ Financial Group Inc (ADR) (NYSE:MTU), Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB), BG Medicine, Inc (NASDAQ:BGMD), Las Vegas Sands Corp (NYSE:LVS)
Mitsubishi UFJ Financial Group Inc (ADR) (NYSE:MTU) showed a volume of 1.12 million shares by the end of last trade whereas the average volume of the stock remained 1.42 million shares. The stock opened the session at $6.62 but then moved to $6.57. At that price, the stock showed a negative performance of -1.65%. Mitsubishi UFJ Financial Group, Inc. is a Japan-based company mainly engaged in the banking business. The Company is also involved in trust banking business, security business, credit card business, leasing business and other businesses. The Company provides asset management, mortgage loan, credit card, insurance, settlement, trust, foreign exchange,
Will MTU Get Buyers Even After The Recent Rally? Find Out Here
Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) opened the session at $2.08 and closed the session at $2.00. The stock showed a negative performance of -3.38% in previous trading session. Navidea Biopharmaceuticals, Inc. (Navidea), formerly Neoprobe Corporation, is a biopharmaceutical company focused on the development and commercialization of precision diagnostic agents. As of December 31, 2011, the Company’s radiopharmaceutical development programs included Lymphoseek (Lymphoseek, Kit for the Preparation of Technetium Tc99m for Injection), a radiopharmaceutical agent for lymph node mapping; AZD4694,
Has NAVB Found The Bottom And Ready To Gain Momentum? Find Out Here
BG Medicine, Inc (NASDAQ:BGMD) opened the session at $1.01 and closed the session at $1.09. The stock showed a positive performance of 4.71% in previous trading session. BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests. Its lead product candidate in development is CardioSCORE, which is a multi-analyte biomarker-based blood test for atherothrombotic cardiovascular disease, commonly known as vulnerable plaque. In March 2011, the Company entered into a supply agreement with Health Diagnostic Laboratory, Inc. (HDL),
Why Should Investors Buy BGMD After The Recent Gain? Just Go Here and Find Out
Las Vegas Sands Corp (NYSE:LVS) the stock advanced 0.90% and finished the session at $79.58. Traded with volume of 3.86 million shares in the prior session and the average volume of the stock remained 3.73 million shares. The beta of the stock remained 3.31. Las Vegas Sands Corp. is a developer of destination properties (integrated resorts) that feature accommodations, gaming, entertainment and retail, convention and exhibition facilities, celebrity chef restaurants and other amenities. The Company owns and operates integrated resorts in Asia and the United States. The Company also offers players club loyalty programs at its properties, which provide access to rewards, privileges and members-only events.
Will LVS Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)